Poor quality vital anti-malarials in Africa - An urgent neglected public health priority

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Newton, Paul N ^a,b,c,d   Green, Michael D ^e   Mildenhall, Dallas C ^f   Plançon, Aline ^g   Nettey, Henry ^e   Nyadong, Leonard ^h   Hostetler, Dana M ^h   Swamidoss, Isabel ^e   Harris, Glenn A ^h   Powell, Kristen ^h   Timmermans, Ans E ⁱ   Amin, Abdinasir A ^j   Opuni, Stephen K ^k   Barbereau, Serge ^l   Faurant, Claude ^m   Soong, Ray C W ^f   Faure, Kevin ^f   Thevanayagam, Jonarthan ^b   Fernandes, Peter ^b   Kaur, Harparkash ^c   Angus, Brian ^b   Stepniewska, Kasia ^b,n   Guerin, Philippe J ^b,d   Fernández, Facundo M ^h   more..

^a MAHOSOT HOSPITAL   (Laos)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f GNS SCIENCE   (New Zealand)

^g International Criminal Police Organization (INTERPOL)   (France)

^h GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

ⁱ ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^j POPULATION SERVICES INTERNATIONAL   (United States)

^k Food and Drugs Board   (Ghana)

^l East West Pharmaceuticals ^*  (France)

^m East West Pharmaceuticals   (France)

ⁿ MAHIDOL UNIVERSITY   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; CHLOROQUINE; COUNTERFEIT DRUG; DIHYDROARTEMISININ; HALOFANTRINE; PARACETAMOL; PIPERAQUINE; PYRIMETHAMINE; SILDENAFIL; ANTIMALARIAL AGENT; ARTEMISIN; LACTONE;

AFRICA; ARTICLE; DRUG FORMULATION; DRUG QUALITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PACKAGING; PUBLIC HEALTH; X RAY; ASIA; CHEMICAL ANALYSIS; CHEMISTRY; DRUG PACKAGING; HEALTH CARE QUALITY; METHODOLOGY; STATISTICS;

AFRICA; ANTIMALARIALS; ARTEMISININS; ASIA; CHEMISTRY TECHNIQUES, ANALYTICAL; COUNTERFEIT DRUGS; DRUG PACKAGING; HUMANS; LACTONES; QUALITY OF HEALTH CARE;

EID: 83255188871     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-352     Document Type: Article

References (51)

1. World Health Organization, WHO guidelines for the treatment of malaria. Geneva 2010 http://whqlibdoc.who.int/publications/2010/9789241547925-eng.pdf Accessed 12 March 2011
2. Arrow KJ, Panosian CB, Gelband H, Saving lives, buying time: Economics of malaria drugs in an age of resistance Washington (DC): Institute of Medicine of the National Academies 2004 http://www.nap.edu/books/0309092183/html/ Accessed 12 October 2011
3. Qinghaosu (artemisinin): the price of success. White NJ, Science 2008 320 330 334 10.1126/science.1155165 18420924 (Pubitemid 351555649)
4. World Health Organization, Country antimalarial drug policies: by region. Geneva 2009 http://www.who.int/malaria/am-drug-policies-by-region-afro/en/ index.html Accessed 12 March 2011
5. th Session Provisional agenda item 4.11. Counterfeit medical products. EB124. World Health Organization, Geneva 2008 http://www.who.int/gb/ebwha/pdf-files/EB124/B124-14-en.pdf. With corrigendum-see http://apps.who.int/gb/ebwha/pdf-files/EB124/B124-14Corr1-en.pdf. Accessed 12 March 2011
6. Manslaughter by fake artesunate in Asia-will Africa be next? Newton PN, McGready R, Fernández F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJ, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NPJ, Greenwood BM, Nosten F, White NJ, PLoS Medicine 2006 3 197 10.1371/journal.pmed.0030197 16752952 (Pubitemid 43987814)
7. What are substandard medicines? World Health Organization, Geneva 2009 http://www.who.int/medicines/services/counterfeit/faqs/06/en/index.html Accessed 12 March 2011
8. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Caudron JM, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J, Trop Med Int Health 2008 13 1062 72 10.1111/j.1365-3156.2008.02106.x 18631318
9. Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003. Leslie T, Kaur H, Mohammed N, Kolaczinski K, Ord RL, Rowland M, Emerg Infect Dis 2009 15 1753 1759 19891862
10. Counterfeit and substandard anti-infectives in developing countries. Newton PN, Fernández FM, Green MD, Primo-Carpenter J, White NJ, Antimicrobial Resistance in Developing Countries New York, Springer, Sosa AJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN, 2009 413 443
11. Impaired clinical response in a patient with uncomplicated falciparum malaria who received poor quality and underdosed intramuscular artemether. Keoluangkhot V, Green M, Nyadong L, Fernández F, Mayxay M, Newton PN, Am J Trop Med Hyg 2008 78 552 555 18385347 (Pubitemid 351845155)
12. Antimalarial drug quality in Africa. Amin AA, Kokwaro GO, J Clin Phar Ther 2007 32 429 440 10.1111/j.1365-2710.2007.00847.x (Pubitemid 47404284)
13. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP, Malar J 2009 8 253 10.1186/1475-2875-8-253 19906307
14. Intercontinental spread of pyrimethamine-resistant malaria. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T, Science 2004 305 1124 10.1126/science.1098876 15326348 (Pubitemid 39100317)
15. Invasion of Africa by a single pfcrt allele of South East Asian type. Ariey F, Fandeur T, Durand R, Randrianarivelojosia M, Jambou R, Legrand E, Ekala MT, Bouchier C, Cojean S, Duchemin JB, Robert V, Le Bras J, Mercereau-Puijalon O, Malar J 2006 5 34 10.1186/1475-2875-5-34 16638153 (Pubitemid 43742435)
16. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 355 1959 1966
17. Antimalarial drug quality in the most severely malarious parts of Africa-a six country study. Bate R, Coticelli P, Tren R, Attaran A, PLoS One 2008 3 2132 10.1371/journal.pone.0002132 18461128 (Pubitemid 352025174)
18. Beware of fake Co-Artem malaria tabs on the market. Hope KE, The Ghanaian Times July 10th 2009
19. Counterfeit antimalarial drug discovered in Ghana with aid of USP Drug Quality and Information Program. United States Pharmacopeia, 2009 Press release, USP, Available at http://www.usp.org/worldwide/. Accessed 12 March 2011
20. NAFDAC impounds N10 Million Fake Malaria Drugs. Udoh F, AllAfrica.com 21 Jan 2010
21. Nigeria: NAFDAC impounds consignments of fake drugs valued at N500 Million. Udoh F, AllAfrica.com 10 June 2010
22. Counterfeit drugs threaten to roll back the gains. Kwei R, Eyes on Malaria (AMREN Magazine) 2009 http://www.eyesonmalaria.org/fourthedition27.html Accessed 12 March 2011
23. Public Alert. The Pharmacy and Poisons Board, Republic of Kenya Ministry of Health, 2007 http://www.pharmacyboardkenya.org Accessed 12 March 2011
24. Counterfeit Drug Forensic Investigation Network-CODFIN. http://www.codfin.org
25. Guidelines for field surveys of the quality of medicines: a proposal. Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S, Phanouvong S, Kaur H, Amin AA, Whitty CJM, Kokwaro GO, Lindegårdh N, Lukulay P, White LJ, Day NPJ, Green MD, White NJ, PLoS Med 2009 6 1000052
26. A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia. Newton PN, Fernández FM, Plançon A, Mildenhall DC, Green MD, Ziyong L, Christophel EM, Phanouvong S, Howells S, McIntosh E, Laurin P, Blum N, Hampton CY, Faure K, Nyadong L, Soong SWR, Santoso B, Zhiguang W, Newton J, Palmer K, PLoS Med 2008 5 32 10.1371/journal.pmed.0050032 18271620 (Pubitemid 351317652)
27. Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. Green MD, Nettey H, Villalva Rojas O, Pamanivong C, Khounsaknalath L, Ortiz MG, Newton PN, Fernández FM, Vongsack L, Manolin O, J Pharm Biomed Anal 2007 43 105 110 10.1016/j.jpba.2006.06.047 16930916 (Pubitemid 44873183)
28. Characterization of solid counterfeit drug samples by desorption electrospray ionization and direct-analysis-in-real-time coupled to time-of-flight mass spectrometry. Fernández FM, Cody RB, Green MD, Hampton CY, McGready R, Sengaloundeth S, White NJ, Newton PN, Chem Med Chem 2006 1 702 705 16902921 (Pubitemid 44154357)
29. Reactive desorption electrospray ionization linear ion trap mass spectrometry of latest-generation counterfeit antimalarials via noncovalent complex formation. Nyadong L, Green MD, De Jesus VR, Newton PN, Fernández FM, Anal Chem 2007 79 2150 2157 10.1021/ac062205h 17269655 (Pubitemid 46355251)
30. The United States Pharmacopeia, The United States Pharmacopeia Washington, D.C., USA. The United States Pharmacopeial Convention 2005
31. Malaria drugs recalled in Kenya. Anon, BBC News 17 Aug 2007 http://news.bbc.co.uk/1/hi/world/africa/6951586.stm Accessed 12 March 2011
32. Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. Ioset JR, Kaur H, PLoS One 2009 4 7270 10.1371/journal.pone.0007270 19789707
33. Identification of the 'wrong' active pharmaceutical ingredient in a counterfeit Halfan drug product using accurate mass electrospray ionization mass spectrometry, accurate mass tandem mass spectrometry and liquid chromatography/mass spectrometry. Wolff JC, Thomson LA, Eckers C, Rapid Comm Mass Spect 2003 17 215 221 10.1002/rcm.893 (Pubitemid 36164169)
34. East Africa's Operation Mamba III bolsters fight against counterfeit medicines with INTERPOL-IMPACT support. INTERPOL, 26th Aug 2010 http://www.interpol.int/Public/ICPO/PressReleases/PR2010/PR065.asp Accessed 12 March 2011
35. Survey of the quality of selected antimalarial medicines circulating in Madagascar, Senegal, and Uganda. United States Pharmacopeia, United States Pharmacopeial Convention 2009 http://www.usaid.gov/our-work/global-health/hs/ publications/qamsa-report-1109.pdf Accessed 12 March 2011
36. Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa. World Health Organization, WHO/EMP/QSM/2011.1 World Health Organization. Geneva 2011 http://www.who.int/ medicines/publications/WHO-QAMSA-report.pdf Accessed 12 March 2011
37. A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR-implications for therapeutic failure and drug resistance. Sengaloundeth S, Green MD, Fernández FM, Manolin O, Phommavong K, Insixiengmay V, Hampton CY, Nyadong L, Mildenhall DC, Hostetler D, Khounsaknalath L, Vongsack L, Phompida S, Vanisaveth V, Syhakhang L, Newton PN, Malar J 2009 8 172 10.1186/1475-2875-8-172 19638225
38. Anon, British National Formulary No 56 BMJ Group and RPS Publishing, London 2008
39. Drug Resistance Maps. http://drugresistancemaps.org/
40. Worldwide Antimalarial Resistance Network, http://www.wwarn.org/
41. Return of chloroquine antimalarial efficacy in Malawi. Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV, N Engl J Med 2006 361 455 467
42. GlaxoSmithKline case study. Anon, Judicial Protection of IPR in China 2003 http://www.chinaiprlaw.com/english/news/news14.htm Accessed 12 March 2011
43. NAFDAC raids fake drug label printing house. Edike T, Vanguard (Lagos) 12 Dec 2003
44. Combating counterfeit drugs. Anon, Lancet 2008 371 1551 10.1016/S0140-6736(08)60663-7 18468523 (Pubitemid 351626824)
45. Counterfeit and substandard drugs. Frequently asked questions. World Health Organization, World Health Organization, Geneva 2005 http://www.who.int/ medicines/services/counterfeit/faqs/en/ Accessed 12 March 2011
46. Assessment of medicines regulatory systems in sub-Saharan African countries. World Health Organization, World Health Organization, Geneva 2011 http://apps.who.int/medicinedocs/en/m/abstract/Js17577en/ Accessed 12 March 2011
47. WHO list of prequalified quality control laboratories. World Health Organization, World Health Organization, Geneva 2010 http://apps.who.int/ prequal/lists/PQ-QCLabsList.pdf Accessed 12 March 2011
48. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Yeung S, Van Damme W, Socheat D, White NJ, Mills A, Malar J 2008 7 96 10.1186/1475-2875-7-96 18510724 (Pubitemid 351990315)
49. The Cotonou Declaration. Fondation Chirac, 2009 http://www. fondationchirac.eu/en/the-cotonou-declaration-october-12-2009-benin/ Accessed 12 March 2011
50. International Health Regulations. World Health Organization, World Health Organization, Geneva 2005 http://whqlibdoc.who.int/publications/2008/ 9789241580410-eng.pdf Accessed 12 March 2011
51. Why and how to make an international crime of medicine counterfeiting. Attaran A, Bate R, Kendall M, J Int Criminal Justice 2011 doi:10.1093/jicj/ mqr005